Factor V G1691A and prothrombin G20210A in angiographically documented coronary artery disease patients with and without type 2 diabetes mellitus

被引:0
|
作者
Rahimi, Z.
Mozafari, H.
Rezaei, M.
Nagel, R. I.
Muniz, A.
机构
[1] Kermanshah Univ Med Sci, Kermanshah, Iran
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0952
引用
下载
收藏
页码:354 / 355
页数:2
相关论文
共 50 条
  • [41] Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction
    Forte, Giusi Irma
    Vaccarino, Loredana
    Palmeri, Marisa
    Branzi, Angelo
    Caldarera, Claudio M.
    Scola, Letizia
    Caruso, Calogero
    Licastro, Federico
    Lio, Domenico
    BIOGERONTOLOGY, 2011, 12 (05) : 485 - 490
  • [42] Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease
    Renner, W
    Köppel, H
    Brodmann, M
    Pabst, E
    Schallmoser, K
    Toplak, H
    Wascher, TC
    Pilger, E
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (01) : 20 - 22
  • [43] The G1691A Mutation of the Factor V Gene (Factor V Leiden) and the G20210A Mutation of the Prothrombin Gene as Risk Factors in Thrombotic Microangiopathies
    Sucker, Christoph
    Kurschat, Christine
    Hetzel, Gerd R.
    Grabensee, Bernd
    Maruhn-Debowski, Beate
    Loncar, Robert
    Ostojic, Ljerka
    Scharf, Ruediger E.
    Zotz, Rainer B.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (03) : 360 - 363
  • [44] Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients
    Yasa, Mehmet Hadi
    Bolaman, Zahit
    Yukselen, Vahit
    Kadikoylu, Gurhan
    Karaoglu, Ali Onder
    Batun, Sabri
    HEPATO-GASTROENTEROLOGY, 2007, 54 (77) : 1438 - 1442
  • [45] Low prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in Thai population
    Angchaisuksiri, P
    Pingsuthiwong, S
    Aryuchai, K
    Busabaratana, M
    Sura, T
    Atichartakarn, V
    Sritara, P
    THROMBOSIS AND HAEMOSTASIS, 1999, : 185 - 185
  • [46] First thromboembolic onset in children carrying either the heterozygeous factor V G1691A mutation or the prothrombin G20210A variant
    Kosch, A
    Becker, S
    Kurnik, K
    Sudbrak, K
    Schobess, R
    Junker, R
    Käse, M
    Nowak-Göttl, U
    32ND HEMOPHILIA SYMPOSIUM, 2003, : 103 - 110
  • [47] Factor-V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with preeclampsia, a case -control study
    Ahmed, Nadir A.
    Adam, Ishag
    Elzaki, Salah Eldin G.
    Awooda, Hiba A.
    Hamdan, Hamdan Z.
    BMC MEDICAL GENETICS, 2019, 20
  • [48] Impact of the G1691A Factor V, G20210A Prothrombin Gene Mutations and acquired risk factors on thrombosis risk in patients with gastrointestinal carcinoma
    Mandala, M.
    Falanga, A.
    Cremonesi, M.
    Floriani, I.
    Zaccanelli, M.
    Vigano, M.
    Cazzaniga, M.
    Cabiddu, M.
    Barni, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 379 - 379
  • [49] Factor VLeiden and prothrombin G20210A gene polymorphisms in patients with coronary artery disease
    Ercan, Bahadir
    Tamer, Lueluefer
    Sucu, Nehir
    Pekdemir, Hasan
    Camsan, Ahmet
    Atik, Ugur
    YONSEI MEDICAL JOURNAL, 2008, 49 (02) : 237 - 243
  • [50] The impact of factor V Leiden and G20210A prothrombin mutations on carotid stenosis in type 2 diabetes mellitus
    Frengidis, T.
    Theodoridis, A.
    Lambropoulos, A.
    ARCHIVES OF HELLENIC MEDICINE, 2010, 27 (04): : 643 - 649